Abstract
Thirty-five women with metastatic breast cancer received a battery of baseline psychological tests; results were correlated with length of survival. Patients who died in less than one year from baseline were categorized as short-term survivors, while patients who lived for one year or longer were assigned to the long-term survivor group. The long-term survivors were more symptomatic overall, with particular elevations on measures of anxiety and alienation, and substantially higher levels of dysphoric mood (eg, depression, guilt) than the short-term survivors. Short-term survivors revealed significantly lower levels of hostility, with higher levels of positive mood. Treating oncologists perceived the long-term survivors to show significantly poorer adjustment to their illnesses than the short-term survivors, and an interviewer's ratings indicated that long-term survivors had significantly poorer attitudes toward their physicians. Measures of clinical status and demographic data revealed few differences between the two groups. (JAMA 242:1504-1508, 1979).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1504-1508 |
| Number of pages | 5 |
| Journal | JAMA: The Journal of the American Medical Association |
| Volume | 242 |
| Issue number | 14 |
| DOIs | |
| State | Published - Oct 5 1979 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Psychological Coping Mechanisms and Survival Time in Metastatic Breast Cancer. / Derogatis, Leonard; Abeloff, Martin D.; Melisaratos, Nick.
In: JAMA: The Journal of the American Medical Association, Vol. 242, No. 14, 05.10.1979, p. 1504-1508.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Psychological Coping Mechanisms and Survival Time in Metastatic Breast Cancer
AU - Derogatis, Leonard
AU - Abeloff, Martin D.
AU - Melisaratos, Nick
PY - 1979/10/5
Y1 - 1979/10/5
N2 - Thirty-five women with metastatic breast cancer received a battery of baseline psychological tests; results were correlated with length of survival. Patients who died in less than one year from baseline were categorized as short-term survivors, while patients who lived for one year or longer were assigned to the long-term survivor group. The long-term survivors were more symptomatic overall, with particular elevations on measures of anxiety and alienation, and substantially higher levels of dysphoric mood (eg, depression, guilt) than the short-term survivors. Short-term survivors revealed significantly lower levels of hostility, with higher levels of positive mood. Treating oncologists perceived the long-term survivors to show significantly poorer adjustment to their illnesses than the short-term survivors, and an interviewer's ratings indicated that long-term survivors had significantly poorer attitudes toward their physicians. Measures of clinical status and demographic data revealed few differences between the two groups. (JAMA 242:1504-1508, 1979).
AB - Thirty-five women with metastatic breast cancer received a battery of baseline psychological tests; results were correlated with length of survival. Patients who died in less than one year from baseline were categorized as short-term survivors, while patients who lived for one year or longer were assigned to the long-term survivor group. The long-term survivors were more symptomatic overall, with particular elevations on measures of anxiety and alienation, and substantially higher levels of dysphoric mood (eg, depression, guilt) than the short-term survivors. Short-term survivors revealed significantly lower levels of hostility, with higher levels of positive mood. Treating oncologists perceived the long-term survivors to show significantly poorer adjustment to their illnesses than the short-term survivors, and an interviewer's ratings indicated that long-term survivors had significantly poorer attitudes toward their physicians. Measures of clinical status and demographic data revealed few differences between the two groups. (JAMA 242:1504-1508, 1979).
UR - http://www.scopus.com/inward/record.url?scp=0018720087&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018720087&partnerID=8YFLogxK
U2 - 10.1001/jama.1979.03300140020016
DO - 10.1001/jama.1979.03300140020016
M3 - Article
C2 - 470087
AN - SCOPUS:0018720087
VL - 242
SP - 1504
EP - 1508
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0098-7484
IS - 14
ER -